Research Study
We are conducting a registry for patients with moderate to severe chronic plaque psoriasis (CPP) being treated with Humira® (adalimumab). This registry is also known as ESPRIT.ESPRIT is an international research program collecting information on about 6,000 psoriasis patients. This registry is being done to help doctors understand how well Humira® works for treating psoriasis.
By taking part in ESPRIT, you will help us to collect important information on patients with psoriasis who are being treated with Humira®. Humira® has been approved for the treatment of moderate to severe chronic plaque psoriasis. If you decide to sign up for ESPRIT, my physician assistant, Renata Block, will explain the details to you.If you would like to find out more about ESPRIT, please call my office at the phone number below. I hope that you will consider joining this important research program.
Sincerely,
Kevin S. Pinski, M.D.
To schedule your appointment, or for additional information, call:
(312) 263-4625